MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Q.
Right arrow Articles by Cederbaum, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Q.
Right arrow Articles by Cederbaum, A. I.

0026-895X/97/040648-10$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:648-657 (1997).

Menadione Cytotoxicity to Hep G2 Cells and Protection by Activation of Nuclear Factor-kappa B

Qi Chen and Arthur I. Cederbaum

Department of Biochemistry, Mount Sinai School of Medicine, New York, New York 10029

Menadione (vitamin K-3,2-methyl-1,4-naphthoquinone), a redox cycling reagent, generates reactive oxygen intermediates and causes oxidative injury. The addition of menadione to Hep G2 cells produced a time- and concentration-dependent loss of cell viability. Preincubation of Hep G2 cells with low, nontoxic concentrations of menadione increased the viability of the cells against toxic doses of menadione or H2O2. Maximum protection was found with menadione concentrations of ~3 µM and preincubation times of ~45 min. This protective effect could be blocked by the protein synthesis inhibitor cycloheximide and by a variety of antioxidants. The transcription factor nuclear factor-kappa F (NF-kappa B) is known to be activated by many compounds, including reactive oxygen intermediates. Menadione activated NF-kappa B as determined by electrophoretic mobility shift assays. This activation was prevented by the same antioxidants that blocked protection against cytotoxicity produced by preincubation with menadione. Anti-p50 IgG prevented the menadione-stimulated binding of NF-kappa B to the oligonucleotide probe, whereas anti-p65 IgG produced a supershift of the NF-kappa B/oligonucleotide complex. Salicylate prevented the activation of NF-kappa B by menadione, and under these conditions, salicylate potentiated the cytotoxicity of menadione or H2O2. Transfection with a plasmid containing cDNA encoding mouse Ikappa Bbeta , an inhibitor of NF-kappa B, resulted in increased toxicity by menadione. Furthermore, when protein kinase C was down-regulated by prolonged treatment with active phorbol ester (phorbol-12-myristate-13-acetate), the Hep G2 cells became more sensitive to menadione treatment. However, short term treatment with PMA, which activated NF-kappa B, resulted in protection against menadione cytotoxicity. Menadione cytotoxicity was enhanced when the Hep G2 cells were depleted of GSH. An increased level of GSH was observed after menadione pretreatment; this increase was blocked by salicylate, thereby linking the GSH increase to activation of NF-kappa B by menadione. The results of the current study suggest that menadione pretreatment protects Hep G2 cells from oxidative injury through an NF-kappa B-related mechanism, which may involve, in part, increased production of GSH.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
C. Antachopoulos, J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh
Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species
J. Antimicrob. Chemother., February 1, 2007; 59(2): 230 - 237.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Morissette, E. Moreau, R. C.-Gaudreault, and F. Marceau
N-Substituted 4-Aminobenzamides (Procainamide Analogs): An Assessment of Multiple Cellular Effects Concerning Ion Trapping
Mol. Pharmacol., December 1, 2005; 68(6): 1576 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Jimenez-Lopez and A. I. Cederbaum
Protein Kinase C Signaling as a Survival Pathway against CYP2E1-Derived Oxidative Stress and Toxicity in HepG2 Cells
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 998 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Liu and D. J. Waxman
Post-Transcriptional Regulation of Hepatic NADPH-Cytochrome P450 Reductase by Thyroid Hormone: Independent Effects on Poly(A) Tail Length and mRNA Stability
Mol. Pharmacol., May 1, 2002; 61(5): 1089 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-C. Li, D. Liu, and D. J. Waxman
Transcriptional Induction of Hepatic NADPH: Cytochrome P450 Oxidoreductase by Thyroid Hormone
Mol. Pharmacol., April 16, 2001; 59(5): 987 - 995.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Ishii, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto
Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages
J. Biol. Chem., May 19, 2000; 275(21): 16023 - 16029.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. E. Jones, C. R. Lo, H. Liu, Z. Pradhan, L. Garcia, A. Srinivasan, K. L. Valentino, and M. J. Czaja
Role of caspases and NF-kappa B signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G693 - G699.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J.-Y. Huan and D. R. Koop
Tightly Regulated and Inducible Expression of Rabbit Cyp2e1 Using A Tetracycline-Controlled Expression System
Drug Metab. Dispos., April 1, 1999; 27(4): 549 - 554.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. E. Jones and M. J. Czaja
III. Intracellular signaling in response to toxic liver injury
Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G874 - G878.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics